New Zealand - English - Medsafe (Medicines Safety Authority)

rex medical ltd - vinorelbine tartrate 13.85 mg/ml equivalent to vinorelbine 10 mg/ml - concentrate for injection - 10 mg/ml - active: vinorelbine tartrate 13.85 mg/ml equivalent to vinorelbine 10 mg/ml excipient: nitrogen sodium hydroxide water for injection - second-line treatment of advanced breast cancer, as a single agent or in combination.

New Zealand - English - Medsafe (Medicines Safety Authority)

pierre fabre medicament australia pty ltd - vinorelbine tartrate 27.7mg equivalent to vinorelbine 20 mg - soft gelatin capsule - 20 mg - active: vinorelbine tartrate 27.7mg equivalent to vinorelbine 20 mg excipient: edible ink red ethanol gelatin glycerol   anidrisorb 85/70 85% phosal 53 mct iron oxide yellow macrogol 400 medium-chain triglycerides purified water   titanium dioxide

New Zealand - English - Medsafe (Medicines Safety Authority)

pierre fabre medicament australia pty ltd - vinorelbine tartrate 55.4mg equivalent to vinorelbine 40 mg - soft gelatin capsule - 40 mg - active: vinorelbine tartrate 55.4mg equivalent to vinorelbine 40 mg excipient: edible ink red ethanol gelatin glycerol   anidrisorb 85/70 85% phosal 53 mct iron oxide red iron oxide yellow macrogol 400 medium-chain triglycerides purified water   titanium dioxide

New Zealand - English - Medsafe (Medicines Safety Authority)

pierre fabre medicament australia pty ltd - vinorelbine tartrate 110.8mg equivalent to vinorelbine 80 mg - soft gelatin capsule - 80 mg - active: vinorelbine tartrate 110.8mg equivalent to vinorelbine 80 mg excipient: edible ink red ethanol gelatin glycerol   anidrisorb 85/70 85% phosal 53 mct iron oxide yellow macrogol 400 medium-chain triglycerides purified water   titanium dioxide

Ireland - English - HPRA (Health Products Regulatory Authority)

strides arcolab international limited - vinorelbine tartrate - concentrate for soln for inf - 10 mg/ml

Australia - English - Department of Health (Therapeutic Goods Administration)

medtas pty ltd - vinorelbine tartrate, quantity: 69.25 mg (equivalent: vinorelbine, qty 50 mg) - injection, concentrated - excipient ingredients: water for injections - treatment of advanced breast cancer after failure of standard therapy, as a single agent or in combination; and as a first line treatment for advanced non-small cell lung cancer, as a single agent or in combination.

Australia - English - Department of Health (Therapeutic Goods Administration)

medtas pty ltd - vinorelbine tartrate, quantity: 13.85 mg (equivalent: vinorelbine, qty 10 mg) - injection, concentrated - excipient ingredients: water for injections - treatment of advanced breast cancer after failure of standard therapy, as a single agent or in combination; and as a first line treatment for advanced non-small cell lung cancer, as a single agent or in combination.

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - vinorelbine tartrate -

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - vinorelbine tartrate -

Australia - English - Department of Health (Therapeutic Goods Administration)

amneal pharma australia pty ltd - vinorelbine tartrate, quantity: 69.25 mg (equivalent: vinorelbine, qty 50 mg) - injection, concentrated - excipient ingredients: water for injections - treatment of advanced breast cancer after failure of standard therapy, as a single agent or in combination; and as a first line treatment for advanced non-small cell lung cancer, as a single agent or in combination.